Category: Drug Discovery
Global Drug Discovery
-
Companion Animal Postoperative Pain Management Therapeutics Market by Product (Anesthetics, NSAIDs, Opioids), Animal Type (Canine, Feline) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 149.46 million in 2024, at a CAGR 10.05% to reach USD 265.74 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Companion ... Read More
-
Label-free Array System Market by Technique (Atomic Force Microscopy, Ellipsometry Techniques, Enthalpy Array), Application (Biomolecular Interactions, Detection of Disease Biomarkers, Drug Discovery), End User - Global Forecast 2024-2030
... estimated at USD 1.38 billion in 2023 and expected to reach USD 1.49 billion in 2024, at a CAGR 8.11% to reach USD 2.38 billion by 2030. Global Label-free Array System Market FPNV Positioning Matrix ... Read More
-
Autoimmune Disease Drugs Market by Indication (Diabetes Mellitus Type 1, Multiple Sclerosis, Rare Diseases), Drug Class (Anti-Inflammatory, Antihyperglycemic, Immunosuppressants), Distribution - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 116.79 billion in 2024, at a CAGR 7.52% to reach USD 180.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Polycystic Ovarian Syndrome Treatment Market by Drug Class (Anti-Depressants, Anti-Obesity, Insulin Sensitizing Agents), Surgery (Laparoscopic Ovarian Drilling, Ovarian Wedge Resection), Distribution Channel - Global Forecast 2024-2030
... at USD 3.25 billion in 2023 and expected to reach USD 3.45 billion in 2024, at a CAGR 6.63% to reach USD 5.09 billion by 2030. Global Polycystic Ovarian Syndrome Treatment Market FPNV Positioning Matrix ... Read More
-
Tuberculosis Drugs Market by Disease (Active TB, Latent TB), Drug Class (Combination Drugs, First-line Anti-TB Drugs, Second-line Anti-TB Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 6.28% to reach USD 2.95 billion by 2030. Global Tuberculosis Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Global Forecast 2024-2030
... Market size was estimated at USD 19.14 billion in 2023 and expected to reach USD 21.35 billion in 2024, at a CAGR 11.88% to reach USD 42.02 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
-
Pharmacogenomics Market by Technology (DNA Sequencing, Electrophoresis, Mass Spectrometry), Application (Drug Discovery, Neurology, Oncology) - Global Forecast 2024-2030
... 9.10 billion in 2024, at a CAGR 5.97% to reach USD 12.73 billion by 2030. Global Pharmacogenomics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Pharmacogenomics Market. It offers a ... Read More
-
Clinical Research Services Market by Services (Clinical Trials, Diagnostic Research, Drug Development Consultancy), Indication (Cardio Vascular Disorders, CNS Disorders, Diabetes), End-User, Deployment - Global Forecast 2024-2030
... USD 57.31 billion in 2023 and expected to reach USD 62.69 billion in 2024, at a CAGR 9.47% to reach USD 108.02 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Fetal Bovine Serum Market by Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum), Application (Cell Culture Media, Diagnostics, Drug Discovery), End-User - Global Forecast 2024-2030
... 1.02 billion in 2023 and expected to reach USD 1.08 billion in 2024, at a CAGR 6.44% to reach USD 1.58 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Microbiome Therapeutics Market by Type (FMT, Microbiome Drugs), Application (C. difficile, Crohn’s disease, Diabetes) - Global Forecast 2024-2030
... USD 156.40 million in 2024, at a CAGR 23.77% to reach USD 564.82 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Microbiome Therapeutics Market. It offers a comprehensive ... Read More
-
Gout Therapeutics Market by Drug Class (Colchicine, Corticosteroids, NSAIDs), Treatment (Uricosuria Medication, Xanthine Oxidase Inhibitor), Route of Administration, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 3.05 billion in 2024, at a CAGR 10.95% to reach USD 5.70 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gout Therapeutics ... Read More
-
Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Global Forecast 2024-2030
... reach USD 1.48 billion in 2024, at a CAGR 10.91% to reach USD 2.77 billion by 2030. Aptamers are single-stranded oligonucleotides, including DNA, RNA, or modified nucleic acids, that have the ability to bind specifically ... Read More
-
Infectious Disease Therapeutics Market by Drug (Antibiotics, Antifungal Drugs, Antiparasitic Drugs), Route of Administration (Intravenous, Oral, Topical), Disease, Distribution Channel, End-User - Global Forecast 2024-2030
... 116.21 billion in 2023 and expected to reach USD 121.27 billion in 2024, at a CAGR 4.41% to reach USD 157.28 billion by 2030. Global Infectious Disease Therapeutics Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), End-use (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2024-2030
... reach USD 10.81 billion in 2024, at a CAGR 8.44% to reach USD 17.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Therapeutics Market. It offers a ... Read More
-
Critical Care Therapeutics Market by Drug Class (Albumin, Antithrombin Concentrates, Factor XIII Concentrates), Application (Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty) - Global Forecast 2024-2030
... 4.77 billion in 2023 and expected to reach USD 5.03 billion in 2024, at a CAGR 5.39% to reach USD 6.90 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Hepatitis Therapeutics Market by Type (Hepatitis A, Hepatitis B, Hepatitis C), Drug Class (Immune Modulator, Oral Antiviral), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 30.76 billion in 2024, at a CAGR 4.11% to reach USD 38.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hepatitis Therapeutics ... Read More
-
Anti-vascular Endothelial Growth Factor Therapeutics Market by Therapeutic Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors), Route of Administration (Intravitreal Injections, Oral Administration), Indication - Global Forecast 2024-2030
... estimated at USD 8.49 billion in 2023 and expected to reach USD 9.01 billion in 2024, at a CAGR 8.85% to reach USD 15.38 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 3.03 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 8.24% to reach USD 5.28 billion by 2030. Global Brain Tumor Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Microplate Reader Market (Product Type: Single-mode Readers, and Multi-mode Readers, and Application: Drug Discovery, Genomics & Proteomics Research, Clinical Diagnostics, and Others) - Global Industry Analysis, Share, Share, Growth, Trends, and Forecast 2023-2031
... Market – Scope of Report TMR’s report on the global microplate reader market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Microplate Systems Market by Product (Microplate Pipetting Systems & Dispensers, Microplate Washers, Multi-Mode Microplate Readers), Application (Clinical Diagnostics, Drug Discovery, Genomics & Proteomics Research), End-User - Global Forecast 2024-2030
... estimated at USD 1.11 billion in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 5.25% to reach USD 1.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Bladder Cancer Therapeutics Market by Treatment Type (Chemotherapy, Gene Therapy, Immunotherapy), Bladder Cancer Type (Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Superficial Bladder Cancer), End-User - Global Forecast 2024-2030
... was estimated at USD 5.21 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.23% to reach USD 8.49 billion by 2030. Global Bladder Cancer Therapeutics Market FPNV Positioning ... Read More
-
Human Liver Model Market by Product (2D Models, 3D Bio Printing, Liver Organoids), Application (Drug Discovery, Education) - Global Forecast 2024-2030
... and expected to reach USD 2.53 billion in 2024, at a CAGR 12.06% to reach USD 5.03 billion by 2030. Global Human Liver Model Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Global Pompe Disease Drugs Market 2024-2028
... pompe disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Fabry Disease Drugs Market 2024-2028
... fabry disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Sickle Cell Anemia Therapeutics Market Research Report 2024(Status and Outlook)
... carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS). The Global Sickle Cell ... Read More
Research Assistance
